These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9644603)

  • 21. [Experience in combination therapy with amikacin and cephapirin for infections complicated with acute leukemia during induction chemotherapy].
    Hasegawa S; Nakao I
    Jpn J Antibiot; 1984 Sep; 37(9):1631-6. PubMed ID: 6512982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory and clinical studies on imipenem/cilastatin sodium plus amikacin sulfate in patients with severe infections complicating hematological disorders].
    Hotta T; Morishima Y; Saito H; Kodera Y; Hirabayashi N; Tanaka M; Mizuno H; Suzuki H; Kato Y; Morishita Y
    Jpn J Antibiot; 1991 May; 44(5):515-28. PubMed ID: 1880931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of a combination treatment with cefminox and fosfomycin for infections complicated in patients with hematological disorders].
    Seriu T; Tsuda S; Nakai H; Murakami T; Takashima T; Takahashi Y; Tanaka S; Nakagawa H; Nishigaki H; Yokota S
    Jpn J Antibiot; 1991 Nov; 44(11):1197-205. PubMed ID: 1784070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experiences with intravenous drip infusion therapy of amikacin for severe infections in patients of hematological disorder].
    Hanada S; Kodama M; Iwahashi M; Uematsu T; Utsunomiya A; Kato Y; Nishioka K; Nomura K; Hashimoto S; Kikuchi H; Matsumoto T; Matsumoto M; Yunoki K
    Jpn J Antibiot; 1982 May; 35(5):1249-53. PubMed ID: 7131757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial of combination antibiotic therapy in patients with hematological disorders. Hanshin Study Group of Hematopoietic Disorders and Infection.
    Takemoto Y; Kanamaru A; Nagai K; Masaoka T; Kitani T; Horiuchi A; Yonezawa T; Yasunaga K; Kageyama T; Tatsumi N
    Jpn J Antibiot; 1990 Jan; 43(1):63-9. PubMed ID: 2190015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of sulbactam/cefoperazone for infections during the chemotherapy of hematologic malignancy].
    Kawai Y; Ueda T; Iwasaki H; Nakamura T
    Jpn J Antibiot; 1994 Sep; 47(9):1196-201. PubMed ID: 7990260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD
    Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
    Ohyashiki K
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S56-8. PubMed ID: 15250023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of aztreonam for infections accompanying febrile neutropenic children with hematologic disorders and solid tumors. A cooperative study].
    Hirotsu T; Akatsuka J; Hoshi Y; Uchiyama H; Fujisawa K; Kobayashi N; Ishidoya N; Ohira M; Takayama J; Ishida Y
    Jpn J Antibiot; 1990 Dec; 43(12):2069-77. PubMed ID: 2086821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care.
    Gouin F; Papazian L; Martin C; Albanese J; Durbec O; Domart Y; Veyssier P; Leroy J; Grès JJ; Rollin C
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():205-14. PubMed ID: 8150764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L; Devecioglu O; Anak S; Karakas Z; Yalman N; Biner B; Eryilmaz E; Goksan B; Unuvar A; Agirbasli H; Can M; Bilgen H; Gedikoglu G
    J Chemother; 2001 Jun; 13(3):281-7. PubMed ID: 11450887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders].
    Hirakawa K; Tsuda S; Misawa S; Ueda Y; Kaneko H; Nakao M; Ariyama Y; Nakai H; Seriu T; Takashima T
    Jpn J Antibiot; 1994 May; 47(5):521-9. PubMed ID: 8051794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic effects of a combination treatment with cefmetazole and netilmicin against infections complicated with hematological disorders].
    Yamane T; Nakao Y; Yasui Y; Ota K; Ohira H; Inoue T; Furukawa Y; Hiyoshi M; Sasaki A; Kishida T
    Jpn J Antibiot; 1990 Nov; 43(11):1843-9. PubMed ID: 2287053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of fever in neutropenic patients with acute leukemia: current role of ceftazidime plus amikacin as empiric therapy.
    Fanci R; Paci C; Martinez RL; Fabbri A; Pecile P; Leoni F; Longo G
    J Chemother; 2000 Jun; 12(3):232-9. PubMed ID: 10877519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
    Tamura K; Imajo K; Akiyama N; Suzuki K; Urabe A; Ohyashiki K; Tanimoto M; Masaoka T;
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S15-24. PubMed ID: 15250016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of cefozopran as treatment for febrile neutropenia].
    Saito T; Hara M; Shinagawa K; Nawa Y; Nakase K; Takeuchi M; Miyata A; Fukuda S; Sunami K; Imajoh K; Yano T; Kojima K; Teshima T; Fujii N; Ishimaru F; Ikeda K; Harada M; Tanimoto M
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):61-5. PubMed ID: 14750323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combined cefotaxime-amikacin treatment of infectious episodes in acute leukaemia patients with therapeutically-induced bone marrow aplasia (author's transl)].
    Guy H; Chavanet P; Portier H; Kazmierczak A; Cortet P
    Nouv Presse Med; 1981 Feb; 10(8):654-6. PubMed ID: 6259613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia.
    Casali A; Ameglio F; Gionfra T; Tonachella R; Paoletti G; Gallo Curcio C
    Chemioterapia; 1987 Dec; 6(6):440-4. PubMed ID: 3325175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
    Minami N; Uno N; Shirakawa S; Ohno R; Okumura M; Yamamoto M; Mitomo Y; Hirano M; Shimizu S; Yamada K
    Jpn J Antibiot; 1986 Mar; 39(3):713-20. PubMed ID: 3488423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M; Velluti G
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.